Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension

By Adeagbo A.S.O.   Joshua I.G.   Falkner C.   Matheson P.J.  

European Journal of Pharmacology, Vol. 481, Iss. 1, 2003-11 ,pp. : 91-100

Elsevier

Access to resources Recommend Favorite

Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery

By Randall M.D.   McCulloch A.I.   Kendall D.A.  

European Journal of Pharmacology, Vol. 333, Iss. 2, 1997-08 ,pp. : 191-197

Elsevier

Access to resources Recommend Favorite

Endothelium and cannabinoid receptor involvement in levcromakalim vasorelaxation

By White R.   Hiley C.R.  

European Journal of Pharmacology, Vol. 339, Iss. 2, 1997-11 ,pp. : 157-160

Elsevier

Access to resources Recommend Favorite

Endothelium-derived Hyperpolarizing Factor Does not Contribute to the Decrease in Endothelium-dependent Relaxation in the Aorta of Streptozotocin-induced Diabetic Rats

By Endo K.   Abiru T.   Machida H.   Kasuya Y.   Kamata K.  

General Pharmacology, Vol. 26, Iss. 1, 1995-01 ,pp. : 149-153

Elsevier

Access to resources Recommend Favorite

Are endothelium-derived hyperpolarizing and contracting factors isoprostanes?

By Janssen L.J.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 2, 2002-02 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite